GEORGE A. OMURA, M.D.; VINOD KANSAL, M.D.
To the editor: As noted by Grann and associates in "The Therapy of Acute Granulocytic Leukemia in Patients More than 50 Years Old" (Ann Intern Med 80:15-20, 1974), we also have had favorable results in some of our older patients; however, the problem of selecting patients for therapy remains troublesome. We found that an adult who was already bedridden was not likely to benefit from treatment. In a more graded assessment, the pretreatment performance status, as defined by Karnofsky (1), versus complete remission was tabulated for our series of older patients with acute myelogenous leukemia. With a value of 50%
OMURA GA, KANSAL V. Acute Leukemia Therapy After Age 50. Ann Intern Med. ;80:776–777. doi: 10.7326/0003-4819-80-6-776_2
Download citation file:
Published: Ann Intern Med. 1974;80(6):776-777.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use